Literature DB >> 15194442

EGF-dependent cell cycle progression is controlled by density-dependent regulation of Akt activation.

C M LeVea1, J E Reeder, R A Mooney.   

Abstract

The normal human breast epithelial cell line, MCF10A, was used to investigate the mechanism by which high-density inhibits EGF-dependent cell cycle progression. EGF-dependent Akt activation was found to be transient in high-density cells and sustained in low-density cells. High-density cells also showed decreased EGF receptor (EGFR) autophosphorylation, decreased retinoblastoma protein phosphorylation, and increased p27 protein expression. Although EGFR activation was decreased in the high-density cells, the activation was sufficient to stimulate EGFR substrates comparable to low-density cells. EGF-dependent activation of the Erk1/2 pathway and the upstream activators of Akt (Gab1, erbB3, PI3 kinase, and PDK1) showed no density dependency. Antagonists of Akt activity provided further evidence that regulation of Akt activation is the critical signal transduction step controlling EGF-dependent cell cycle progression. Both adenovirus-mediated expression of dominant-negative Akt and inhibition of PI3 kinase-mediated Akt activation with LY294002 blocked cell cycle progression of low-density cells. In summary, we report the novel finding that high-density blocks EGF-dependent cell cycle progression by inhibiting EGF signaling at the level of EGF-dependent Akt activation rather than at the level of EGFR activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194442     DOI: 10.1016/j.yexcr.2004.03.026

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Royalactin induces queen differentiation in honeybees.

Authors:  Masaki Kamakura
Journal:  Nature       Date:  2011-04-24       Impact factor: 49.962

2.  Human corneal endothelial cells employ phosphorylation of p27(Kip1) at both Ser10 and Thr187 sites for FGF-2-mediated cell proliferation via PI 3-kinase.

Authors:  Jeong Goo Lee; Jong-Suk Song; Ronald E Smith; Eunduck P Kay
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

3.  Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.

Authors:  F Farabegoli; C Ceccarelli; D Santini; M Taffurelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Ali Mandegary; Seyed Noureddin Nematollahi-Mahani; Ehsan Janzamin
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-05-25       Impact factor: 2.416

5.  Epidermal growth factor receptor potentiates MCM7-mediated DNA replication through tyrosine phosphorylation of Lyn kinase in human cancers.

Authors:  Tzu-Hsuan Huang; Longfei Huo; Ying-Nai Wang; Weiya Xia; Yongkun Wei; Shih-Shin Chang; Wei-Chao Chang; Yueh-Fu Fang; Chun-Te Chen; Jing-Yu Lang; Chun Tu; Yan Wang; Ming-Chuan Hsu; Hsu-Ping Kuo; How-Wen Ko; Jia Shen; Heng-Huan Lee; Pei-Chih Lee; Yun Wu; Chung-Hsuan Chen; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2013-06-10       Impact factor: 31.743

6.  BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells.

Authors:  Beate C Litzenburger; Hyun-Jung Kim; Isere Kuiatse; Joan M Carboni; Ricardo M Attar; Marco M Gottardis; Craig R Fairchild; Adrian V Lee
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

7.  Epidermal growth factor improves developmental competence and embryonic quality of singly cultured domestic cat embryos.

Authors:  Chommanart Thongkittidilok; Theerawat Tharasanit; Nucharin Songsasen; Thanida Sananmuang; Sirirak Buarpung; Mongkol Techakumphu
Journal:  J Reprod Dev       Date:  2015-05-17       Impact factor: 2.214

8.  Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.

Authors:  J O Humtsoe; R H Kramer
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

9.  LXRβ controls glioblastoma cell growth, lipid balance, and immune modulation independently of ABCA1.

Authors:  Deven Patel; Fahim Ahmad; Diane M Kambach; Qian Sun; Alan S Halim; Tamalee Kramp; Kevin A Camphausen; Jayne M Stommel
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.